Quest Diagnostics Continuing Medical Education

Welcome to the Quest Diagnostics Continuing Medical Education (CME) page. Below are links to CME learning opportunities that are available to you with the permission of the accredited providers. Activities were selected, whether in part or in whole, for their appropriateness to the practice of clinical medicine.

Prescription Drug Monitoring in Chronic Opioid Therapy: Employing Urine Drug Testing to Optimize Patient Outcomes

Description: Prescription drug monitoring is an effective tool to help mitigate risks associated with opioid therapy, such as misuse, abuse, overdose, and death. The most objective method of assessing medication adherence and misuse is urine drug testing (UDT). In this 15-minute video, 2 experts will discuss how to appropriately order UDT for patients receiving opioid therapy in order to 1) monitor and improve patient medication adherence, and 2) to assess for concomitant use of non-prescribed medications or drugs of abuse

This link is presented with permission from Pri-Med

CME Expiration Date: 06/22/2019

Autoantibody Testing for Connective Tissue Diseases: Primary Care Update

Description: This 30-minute Video Expert Dialogue discusses the role of autoantibody testing in evaluating autoimmune diseases or, more precisely, connective tissue diseases. Topics include how testing for autoantibodies, such as antinuclear antibodies (ANA), can be used in the primary care setting to diagnose autoimmune disorders. The emphasis is on the unique role primary care providers play in diagnosing and managing auitoimmune disorders and optimizing patient care.

This link is presented with permission from Medtelligence and PIM

CME Expiration Date: 03/26/2019

Expert Review of Case Studies for Autoantibody Testing for Autoimmune Diseases

Description: This innovative, 45-minute, case-based CME activity features two prominent faculty covering important, timely issues and data related to the detection of autoimmune (AI) disorders, including evaluation and utilization of current biomarkers for diagnosis of early RA (such as antinuclear antibody (ANA) presence, CCP antibody, 14-3-3η protein). Using case studies, the faculty will explore diagnosis and management strategies to maximize patient care.

This link is presented with permission from Medtelligence and PIM

CME Expiration Date: 04/27/2019

2018 National Lipid Association Spring Clinical Lipid Update Highlights

Description: This CME activity highlights presentations from selected sessions of the live NLA Spring Clinical Lipid Update conference. Experts discuss cardiovascular disease risk factor scoring and clinical assessment, genetic testing and its clinical utility in the diagnosis of familial hypercholesterolemia (FH), type 2 diabetes medications lending to cardiovascular risk reduction, and the role of human genetics in the efficacy of CETP inhibition.

This link is presented with permission from National Lipid Association (NLA)

CME Expiration Date: 04/19/2019

Evidence for the Increasing Role of Natriuretic Peptides in the Diagnosis and Management of Heart Failure.

Description: This webinar discusses evidence for the utility of natriuretic peptide testing to improve outcome, and presents case studies on the management of heart failure after admission and discharge.

This link is presented with permission from Medavera

CME Expiration Date: 11/29/2019

The Spectrum of Molecular Testing Protocols for HCV: Identifying and Monitoring Disease Progression and Treatment Efficacy

Description: Over the last few years, a number of innovative new treatment options for chronic hepatitis C virus (HCV) have become available, including several new direct-acting antiviral agents (DAAs). The emerging class of DAAs currently includes 3 NS3-4A protease inhibitors, 5 NS5A inhibitors, and 2 NS5B polymerase inhibitors, which are used in various combinations to treat the HCV genotypes 1-6. Learn how utilization of DAAs has dramatically advanced the standard of care for HCV, leading to enhanced efficacy, fewer side effects, and better outcomes for patients.

This link is presented with permission from Haymarket Medical Education

CME Expiration Date: 08/31/2018

For comments or suggestions, please email

These CME activities are provided for informational purposes only and are not intended as medical advice. A physician’s test selection and interpretation, diagnosis, and patient management decisions should be based on his/her education, clinical expertise, and assessment of the patient.